Series B - Cybrexa Therapeutics - Mar 10, 2021 Funding Round Profile - Cointime

Bitcoin $93,703.37 -3.96%
Ethereum $3,420.90 +1.90%
BNB $638.51 -3.17%
Optimism $2.36 +7.68%
Arbitrum $0.94 +10.22%
Solana $236.37 -6.19%
Polygon $0.56 -1.24%
Cosmos $8.01 -7.82%
Avalanche $42.15 +1.34%

Bitcoin $93,703.37 -3.96%
Ethereum $3,420.90 +1.90%
BNB $638.51 -3.17%
Optimism $2.36 +7.68%
Arbitrum $0.94 +10.22%
Solana $236.37 -6.19%
Polygon $0.56 -1.24%
Cosmos $8.01 -7.82%
Avalanche $42.15 +1.34%

Cybrexa Therapeutics

company

Funding Round

Series B

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Mar 2, 2018	Series B	0	Advantage Capital	Detail
Mar 2, 2018	Debt Financing	0	Advantage Capital	Detail